Asset Management
Compare Stocks
5 / 10Stock Comparison
VRTS vs HNNA vs GROW vs CNNE vs DHIL
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management - Global
Restaurants
Asset Management
VRTS vs HNNA vs GROW vs CNNE vs DHIL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management - Global | Restaurants | Asset Management |
| Market Cap | $963M | $81M | $35M | $1.35B | $473M |
| Revenue (TTM) | $831M | $36M | $8M | $424M | $158M |
| Net Income (TTM) | $138M | $8M | $98K | $-513M | $49M |
| Gross Margin | 74.9% | 70.1% | 41.7% | 0.0% | 96.0% |
| Operating Margin | 17.4% | 37.0% | -35.3% | -28.2% | 38.4% |
| Forward P/E | 5.8x | 8.1x | — | — | 9.5x |
| Total Debt | $2.84B | $41M | $83K | $332M | $6.40B |
| Cash & Equiv. | $477M | $72M | $25M | $182M | $42M |
VRTS vs HNNA vs GROW vs CNNE vs DHIL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Virtus Investment P… (VRTS) | 100 | 154.6 | +54.6% |
| Hennessy Advisors, … (HNNA) | 100 | 128.3 | +28.3% |
| U.S. Global Investo… (GROW) | 100 | 125.4 | +25.4% |
| Cannae Holdings, In… (CNNE) | 100 | 38.5 | -61.5% |
| Diamond Hill Invest… (DHIL) | 100 | 164.0 | +64.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRTS vs HNNA vs GROW vs CNNE vs DHIL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRTS is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 7 yrs, beta 1.12, yield 6.5%
- 145.1% 10Y total return vs DHIL's 55.4%
- PEG 0.39 vs HNNA's 2.19
- Lower P/E (5.8x vs 9.5x), PEG 0.39 vs 1.14
HNNA ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 19.9%, EPS growth 38.0%
- Lower volatility, beta 0.27, Low D/E 41.4%, current ratio 12.72x
- NIM 1.7% vs DHIL's 0.7%
- 19.9% NII/revenue growth vs GROW's -23.1%
GROW lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, CNNE doesn't own a clear edge in any measured category.
DHIL carries the broadest edge in this set and is the clearest fit for defensive.
- Beta 0.57, yield 5.7%, current ratio 75115.85x
- 30.9% margin vs CNNE's -121.2%
- +31.4% vs CNNE's -20.1%
- 19.5% ROA vs CNNE's -38.9%, ROIC 1.3% vs -5.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.9% NII/revenue growth vs GROW's -23.1% | |
| Value | Lower P/E (5.8x vs 9.5x), PEG 0.39 vs 1.14 | |
| Quality / Margins | 30.9% margin vs CNNE's -121.2% | |
| Stability / Safety | Beta 0.27 vs VRTS's 1.12, lower leverage | |
| Dividends | 6.5% yield, 7-year raise streak, vs HNNA's 5.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +31.4% vs CNNE's -20.1% | |
| Efficiency (ROA) | 19.5% ROA vs CNNE's -38.9%, ROIC 1.3% vs -5.7% |
VRTS vs HNNA vs GROW vs CNNE vs DHIL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VRTS vs HNNA vs GROW vs CNNE vs DHIL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VRTS leads in 2 of 6 categories
DHIL leads 1 • HNNA leads 1 • GROW leads 0 • CNNE leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DHIL leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
VRTS is the larger business by revenue, generating $831M annually — 98.3x GROW's $8M. DHIL is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to CNNE's -121.2%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $831M | $36M | $8M | $424M | $158M |
| EBITDAEarnings before interest/tax | $205M | $11M | -$2M | $3M | $62M |
| Net IncomeAfter-tax profit | $138M | $8M | $98,000 | -$513M | $49M |
| Free Cash FlowCash after capex | -$67M | $10M | -$235,000 | -$35M | $44.5B |
| Gross MarginGross profit ÷ Revenue | +74.9% | +70.1% | +41.7% | +0.0% | +96.0% |
| Operating MarginEBIT ÷ Revenue | +17.4% | +37.0% | -35.3% | -28.2% | +38.4% |
| Net MarginNet income ÷ Revenue | +16.7% | +28.0% | -4.0% | -121.2% | +30.9% |
| FCF MarginFCF ÷ Revenue | -8.9% | +37.6% | -9.8% | -8.3% | -57.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | -6.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +10.9% | -27.3% | — | -160.8% | +25.3% |
Valuation Metrics
VRTS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 7.2x trailing earnings, VRTS trades at a 26% valuation discount to DHIL's 9.8x P/E. Adjusting for growth (PEG ratio), VRTS offers better value at 0.49x vs HNNA's 2.19x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $963M | $81M | $35M | $1.3B | $473M |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $49M | $10M | $1.5B | $6.8B |
| Trailing P/EPrice ÷ TTM EPS | 7.20x | 8.08x | -104.80x | -1.56x | 9.77x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.76x | — | — | — | 9.48x |
| PEG RatioP/E ÷ EPS growth rate | 0.49x | 2.19x | — | — | 1.18x |
| EV / EBITDAEnterprise value multiple | 16.26x | 3.66x | — | — | 110.39x |
| Price / SalesMarket cap ÷ Revenue | 1.16x | 2.28x | 4.14x | 3.18x | 3.00x |
| Price / BookPrice ÷ Book value/share | 0.96x | 0.82x | 0.77x | 0.81x | 2.70x |
| Price / FCFMarket cap ÷ FCF | — | 6.07x | — | — | — |
Profitability & Efficiency
Evenly matched — HNNA and GROW and DHIL each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
DHIL delivers a 27.0% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-52 for CNNE. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DHIL's 36.26x. On the Piotroski fundamental quality scale (0–9), HNNA scores 7/9 vs GROW's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.5% | +8.5% | +0.2% | -51.8% | +27.0% |
| ROA (TTM)Return on assets | +3.6% | +5.3% | +0.2% | -38.9% | +19.5% |
| ROICReturn on invested capital | +3.0% | +7.3% | -4.7% | -5.7% | +1.3% |
| ROCEReturn on capital employed | +3.7% | +8.7% | -6.2% | -7.3% | +26.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 2 | 5 | 6 |
| Debt / EquityFinancial leverage | 2.74x | 0.41x | 0.00x | 0.33x | 36.26x |
| Net DebtTotal debt minus cash | $2.4B | -$32M | -$24M | $150M | $6.4B |
| Cash & Equiv.Liquid assets | $477M | $72M | $25M | $182M | $42M |
| Total DebtShort + long-term debt | $2.8B | $41M | $83,000 | $332M | $6.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.15x | 10.15x | 600.00x | -25.50x | — |
Total Returns (Dividends Reinvested)
HNNA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HNNA five years ago would be worth $13,958 today (with dividends reinvested), compared to $4,126 for CNNE. Over the past 12 months, DHIL leads with a +31.4% total return vs CNNE's -20.1%. The 3-year compound annual growth rate (CAGR) favors HNNA at 18.8% vs CNNE's -5.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -8.6% | +8.0% | +7.7% | -8.8% | +2.8% |
| 1-Year ReturnPast 12 months | -8.0% | -3.8% | +24.3% | -20.1% | +31.4% |
| 3-Year ReturnCumulative with dividends | +1.3% | +67.7% | +3.3% | -16.8% | +22.4% |
| 5-Year ReturnCumulative with dividends | -32.9% | +39.6% | -55.1% | -58.7% | +30.1% |
| 10-Year ReturnCumulative with dividends | +145.1% | -34.7% | +67.4% | -17.1% | +55.4% |
| CAGR (3Y)Annualised 3-year return | +0.4% | +18.8% | +1.1% | -5.9% | +7.0% |
Risk & Volatility
Evenly matched — HNNA and DHIL each lead in 1 of 2 comparable metrics.
Risk & Volatility
HNNA is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than VRTS's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DHIL currently trades 100.0% from its 52-week high vs CNNE's 64.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 0.27x | 0.70x | 0.96x | 0.57x |
| 52-Week HighHighest price in past year | $215.06 | $13.19 | $3.65 | $21.96 | $175.03 |
| 52-Week LowLowest price in past year | $121.61 | $8.90 | $2.12 | $10.46 | $114.11 |
| % of 52W HighCurrent price vs 52-week peak | +66.9% | +77.8% | +71.8% | +64.6% | +100.0% |
| RSI (14)Momentum oscillator 0–100 | 52.8 | 61.5 | 46.5 | 68.9 | 70.5 |
| Avg Volume (50D)Average daily shares traded | 101K | 9K | 24K | 634K | 22K |
Analyst Outlook
VRTS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VRTS as "Hold", CNNE as "Buy". Consensus price targets imply 19.8% upside for CNNE (target: $17) vs 4.3% for VRTS (target: $150). For income investors, VRTS offers the higher dividend yield at 6.48% vs GROW's 3.46%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | — | Buy | — |
| Price TargetConsensus 12-month target | $150.00 | — | — | $17.00 | — |
| # AnalystsCovering analysts | 11 | — | — | 5 | — |
| Dividend YieldAnnual dividend ÷ price | +6.5% | +5.2% | +3.5% | — | +5.7% |
| Dividend StreakConsecutive years of raises | 7 | 1 | 1 | 1 | 1 |
| Dividend / ShareAnnual DPS | $9.32 | $0.54 | $0.09 | — | $9.98 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.2% | +0.6% | +5.6% | 0.0% | +3.6% |
VRTS leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). DHIL leads in 1 (Income & Cash Flow). 2 tied.
VRTS vs HNNA vs GROW vs CNNE vs DHIL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VRTS or HNNA or GROW or CNNE or DHIL a better buy right now?
For growth investors, Hennessy Advisors, Inc.
(HNNA) is the stronger pick with 19. 9% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Virtus Investment Partners, Inc. (VRTS) offers the better valuation at 7. 2x trailing P/E (5. 8x forward), making it the more compelling value choice. Analysts rate Cannae Holdings, Inc. (CNNE) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRTS or HNNA or GROW or CNNE or DHIL?
On trailing P/E, Virtus Investment Partners, Inc.
(VRTS) is the cheapest at 7. 2x versus Diamond Hill Investment Group, Inc. at 9. 8x. On forward P/E, Virtus Investment Partners, Inc. is actually cheaper at 5. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Virtus Investment Partners, Inc. wins at 0. 39x versus Diamond Hill Investment Group, Inc. 's 1. 14x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VRTS or HNNA or GROW or CNNE or DHIL?
Over the past 5 years, Hennessy Advisors, Inc.
(HNNA) delivered a total return of +39. 6%, compared to -58. 7% for Cannae Holdings, Inc. (CNNE). Over 10 years, the gap is even starker: VRTS returned +145. 1% versus HNNA's -34. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRTS or HNNA or GROW or CNNE or DHIL?
By beta (market sensitivity over 5 years), Hennessy Advisors, Inc.
(HNNA) is the lower-risk stock at 0. 27β versus Virtus Investment Partners, Inc. 's 1. 12β — meaning VRTS is approximately 316% more volatile than HNNA relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 36% for Diamond Hill Investment Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRTS or HNNA or GROW or CNNE or DHIL?
By revenue growth (latest reported year), Hennessy Advisors, Inc.
(HNNA) is pulling ahead at 19. 9% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Hennessy Advisors, Inc. grew EPS 38. 0% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRTS or HNNA or GROW or CNNE or DHIL?
Diamond Hill Investment Group, Inc.
(DHIL) is the more profitable company, earning 30. 9% net margin versus -99. 2% for Cannae Holdings, Inc. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DHIL leads at 38. 4% versus -35. 3% for GROW. At the gross margin level — before operating expenses — DHIL leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRTS or HNNA or GROW or CNNE or DHIL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Virtus Investment Partners, Inc. (VRTS) is the more undervalued stock at a PEG of 0. 39x versus Diamond Hill Investment Group, Inc. 's 1. 14x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Virtus Investment Partners, Inc. (VRTS) trades at 5. 8x forward P/E versus 9. 5x for Diamond Hill Investment Group, Inc. — 3. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNNE: 19. 8% to $17. 00.
08Which pays a better dividend — VRTS or HNNA or GROW or CNNE or DHIL?
In this comparison, VRTS (6.
5% yield), DHIL (5. 7% yield), HNNA (5. 2% yield), GROW (3. 5% yield) pay a dividend. CNNE does not pay a meaningful dividend and should not be held primarily for income.
09Is VRTS or HNNA or GROW or CNNE or DHIL better for a retirement portfolio?
For long-horizon retirement investors, Hennessy Advisors, Inc.
(HNNA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 27), 5. 2% yield). Both have compounded well over 10 years (HNNA: -34. 7%, CNNE: -17. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRTS and HNNA and GROW and CNNE and DHIL?
These companies operate in different sectors (VRTS (Financial Services) and HNNA (Financial Services) and GROW (Financial Services) and CNNE (Consumer Cyclical) and DHIL (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VRTS is a small-cap deep-value stock; HNNA is a small-cap high-growth stock; GROW is a small-cap income-oriented stock; CNNE is a small-cap quality compounder stock; DHIL is a small-cap deep-value stock. VRTS, HNNA, GROW, DHIL pay a dividend while CNNE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.